Association of IL-15 and IP-10 Serum Levels with Cytomegalovirus Infection, CMV Viral Load and Cyclosporine Level After Kidney Transplantation

Overview

Journal Rep Biochem Mol Biol

Specialty Biochemistry

Date 2021 Oct 4

PMID 34604411

Citations 2

Authors

Reza Asadzadeh

Pedram Ahmadpoor

Mohsen Nafar

Shima Samavat

Hassan Nikoueinejad

Morteza Hosseinzadeh

Nahid Mamizadeh

Saeideh Hatami

Elham Masoumi

Aliakbar Amirzargar

Affiliations

Soon will be listed here.

Abstract

Background: Cytomegalovirus (CMV) infection is the most common complications following kidney transplantation. Natural killer (NK) cells demonstrated critical anti-viral role in controlling and elimination of CMV after transplantation. Interleukin-15 (IL-15) is a pleiotropic cytokine that promotes the activity of NK cells and strengthens the acquired immune system. Also, IP10 (CXCL10) is a chemotactic factor which regulates NK cell recruitment and antiviral immune response. We aimed to determine the correlation between the serum levels of IL-15 and IP-10 cytokines with CMV infection, CMV viral load, and cyclosporine as a major immunosuppressive treatment after transplantation.

Methods: Fifty-eight kidney transplant recipient patients without evidence of CMV virus disease before transplantation surgery were included in the study. From the day of transplant surgery, the patients were evaluated based on the presence of CMV Ag pp65, CMV viral load, serum levels of IL-15 & IP-10, Cyclosporine levels (C0 & C2), Glomerular Filtration Rate (GFR), and hematological & biochemical Index, up to 75 days.

Results: Comparison analysis of serum levels of IL-15 and IP-10 showed no significant association with CMV infection in kidney transplant recipients. In addition, CMV viral load and cyclosporine levels at C0 and C2 did not affect patients' IL-15 and IP-10 levels.

Conclusion: The levels of IP-10 and IL-15 cytokines are not affected with CMV infection, even if a viral infection occurs in the early days after transplantation or long afterwards. In addition, taking the different levels of cyclosporine did not affect the cytokines levels. Other mechanisms may play a role in maintaining the levels of these cytokines.

Citing Articles

Identification and verification of inflammatory biomarkers for primary Sjögren's syndrome.

Liu X, Wang H, Wang X, Jiang X, Jin Y, Han Y Clin Rheumatol. 2024; 43(4):1335-1352.

PMID: 38376769 PMC: 10944815. DOI: 10.1007/s10067-024-06901-y.

Dynamics of Inflammatory and Neurodegenerative Biomarkers after Autologous Hematopoietic Stem Cell Transplantation in Multiple Sclerosis.

Ruder J, Dinner G, Maceski A, Berenjeno-Correa E, Muller A, Jelcic I Int J Mol Sci. 2022; 23(18).

PMID: 36142860 PMC: 9503241. DOI: 10.3390/ijms231810946.

References

Bai X, Wilson S, Chmura K, Feldman N, Chan E . Morphometric analysis of Th(1) and Th(2) cytokine expression in human pulmonary tuberculosis. Tuberculosis (Edinb). 2004; 84(6):375-85. DOI: 10.1016/j.tube.2004.05.001. View

Yap M, Boeffard F, Clave E, Pallier A, Danger R, Giral M . Expansion of highly differentiated cytotoxic terminally differentiated effector memory CD8+ T cells in a subset of clinically stable kidney transplant recipients: a potential marker for late graft dysfunction. J Am Soc Nephrol. 2014; 25(8):1856-68. PMC: 4116064. DOI: 10.1681/ASN.2013080848. View

Bekiaris V, Timoshenko O, Hou T, Toellner K, Shakib S, Gaspal F . Ly49H+ NK cells migrate to and protect splenic white pulp stroma from murine cytomegalovirus infection. J Immunol. 2008; 180(10):6768-76. DOI: 10.4049/jimmunol.180.10.6768. View

Booth V, Keizer D, Kamphuis M, Clark-Lewis I, Sykes B . The CXCR3 binding chemokine IP-10/CXCL10: structure and receptor interactions. Biochemistry. 2002; 41(33):10418-25. DOI: 10.1021/bi026020q. View

Taub D, Sayers T, Carter C, Ortaldo J . Alpha and beta chemokines induce NK cell migration and enhance NK-mediated cytolysis. J Immunol. 1995; 155(8):3877-88. View

Alpdogan O, Eng J, Muriglan S, Willis L, Hubbard V, Tjoe K . Interleukin-15 enhances immune reconstitution after allogeneic bone marrow transplantation. Blood. 2004; 105(2):865-73. DOI: 10.1182/blood-2003-09-3344. View

Weseslindtner L, Nachbagauer R, Kundi M, Jaksch P, Kerschner H, Simon B . Human cytomegalovirus infection in lung transplant recipients triggers a CXCL-10 response. Am J Transplant. 2011; 11(3):542-52. DOI: 10.1111/j.1600-6143.2010.03404.x. View

Gangappa S, Kokko K, Carlson L, Gourley T, Newell K, Pearson T . Immune responsiveness and protective immunity after transplantation. Transpl Int. 2008; 21(4):293-303. DOI: 10.1111/j.1432-2277.2007.00631.x. View

Ohata K, Espinoza J, Lu X, Kondo Y, Nakao S . Mycophenolic acid inhibits natural killer cell proliferation and cytotoxic function: a possible disadvantage of including mycophenolate mofetil in the graft-versus-host disease prophylaxis regimen. Biol Blood Marrow Transplant. 2010; 17(2):205-13. DOI: 10.1016/j.bbmt.2010.08.014. View

10.

Nandagopal N, Ali A, Komal A, Lee S . The Critical Role of IL-15-PI3K-mTOR Pathway in Natural Killer Cell Effector Functions. Front Immunol. 2014; 5:187. PMC: 4005952. DOI: 10.3389/fimmu.2014.00187. View

11.

Davis Z, Cooley S, Cichocki F, Felices M, Wangen R, Luo X . Adaptive Natural Killer Cell and Killer Cell Immunoglobulin-Like Receptor-Expressing T Cell Responses are Induced by Cytomegalovirus and Are Associated with Protection against Cytomegalovirus Reactivation after Allogeneic Donor Hematopoietic Cell.... Biol Blood Marrow Transplant. 2015; 21(9):1653-62. PMC: 4557961. DOI: 10.1016/j.bbmt.2015.05.025. View

12.

Cukuranovic J, Ugrenovic S, Jovanovic I, Visnjic M, Stefanovic V . Viral infection in renal transplant recipients. ScientificWorldJournal. 2012; 2012:820621. PMC: 3357934. DOI: 10.1100/2012/820621. View

13.

Lauwerys B, GAROT N, Renauld J, Houssiau F . Cytokine production and killer activity of NK/T-NK cells derived with IL-2, IL-15, or the combination of IL-12 and IL-18. J Immunol. 2000; 165(4):1847-53. DOI: 10.4049/jimmunol.165.4.1847. View

14.

Kotton C, Fishman J . Viral infection in the renal transplant recipient. J Am Soc Nephrol. 2005; 16(6):1758-74. DOI: 10.1681/ASN.2004121113. View

15.

Mao Y, van Hoef V, Zhang X, Wennerberg E, Lorent J, Witt K . IL-15 activates mTOR and primes stress-activated gene expression leading to prolonged antitumor capacity of NK cells. Blood. 2016; 128(11):1475-89. PMC: 5025899. DOI: 10.1182/blood-2016-02-698027. View

16.

Rettinger E, Huenecke S, Bonig H, Merker M, Jarisch A, Soerensen J . Interleukin-15-activated cytokine-induced killer cells may sustain remission in leukemia patients after allogeneic stem cell transplantation: feasibility, safety and first insights on efficacy. Haematologica. 2016; 101(4):e153-6. PMC: 5004389. DOI: 10.3324/haematol.2015.138016. View

17.

Lin S, Kuo M . Effect of cyclosporin A on interleukin-15-activated umbilical cord blood natural killer cell function. Cytotherapy. 2008; 10(4):397-405. DOI: 10.1080/14653240802129885. View

18.

Meyers J, Flournoy N, Thomas E . Risk factors for cytomegalovirus infection after human marrow transplantation. J Infect Dis. 1986; 153(3):478-88. DOI: 10.1093/infdis/153.3.478. View

19.

Carson W, Giri J, Lindemann M, Linett M, Ahdieh M, Paxton R . Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor. J Exp Med. 1994; 180(4):1395-403. PMC: 2191697. DOI: 10.1084/jem.180.4.1395. View

20.

Lee E, Lee Z, Song Y . CXCL10 and autoimmune diseases. Autoimmun Rev. 2008; 8(5):379-83. DOI: 10.1016/j.autrev.2008.12.002. View